Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatment by D. T. Wademan, H. R. Draper, S. E. Purchase, M. Palmer, A. C. Hesseling, L. Van der Laan, A. J. Garcia-Prats

Get full text

Children’s preferences among six novel moxifloxacin and linezolid-dispersible tablet formulations by G. Hoddinott, H.R. Draper, N. Vanqa, S. Myeni, S. Staples, T. Sachs, M. Raffique, N. Tshethu, M. Palmer, L. Viljoen, K. Inabathina, R. Taneja, A.C. Hesseling, A.J. Garcia-Prats

Get full text

Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countries by L. Viljoen, H.R. Draper, N.T. Castillo-Carandang, N. Suryavanshi, A. Marthinus, A.M.A. Cheong, J.D.D. Ocampo, G. Dhumal, S. Bagchi, D.T. Wademan, A. Kinikar, M. Paradkar, M.V.G. Frias IV, D.J.O. Casalme, A.C. Hesseling, A.J. Garcia-Prats, M. Palmer, G. Hoddinott, on behalf of the CATALYST trial team

Get full text